Effect of adjuvant chemotherapy for stage IA vessel invasion positive non-small cell lung cancer
Not Applicable
- Conditions
- Patients with completely resected stage IA NSCLC, in which vessel invasions are observed
- Registration Number
- JPRN-UMIN000005921
- Lead Sponsor
- ung Oncology Group in Kyushu, Japan (LOGIK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with drug allergy 2. Patients with contraindication of UFT administration 3.Patients with severe complication (bowel paralysis,ileus,pneumonia,emphysema,lung fibrosis or interstitial pneumonia,uncontrollable DM,heart failure,renal failure,and liver failure)4.Patients with watery diarrhea 5.Women who have possibility(will)with gestation and pregnant or breast feeding women 6.Men who have will with making bady 7.Doctor judged inadequate patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 5-year survival rate
- Secondary Outcome Measures
Name Time Method Completion rate, recurrent rate, drug toxicity, 3-year survival rate, 3- and 5-year disease free survival rates.